Selenium and cancer: A story that should not be forgotten-insights from genomics

Cancer Treatment and Research

Volumn 159, Issue , 2014, Pages 145-166

  Méplan, Catherine ^a   Hesketh, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Colorectal cancer; Micronutrient; Prostate cancer; Selenoproteins; SNP; Transcriptomics

Indexed keywords

GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN; SELENOPROTEIN P; SELENOPROTEIN S; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; COLORECTAL CANCER; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; GENE; GENE EXPRESSION REGULATION; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GPX1 GENE; GPX2 GENE; GPX4 GENE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUTRIGENOMICS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; SELENIUM DEFICIENCY; SEP15 GENE; SEPP GENE; SEPP1 GENE; SEPS GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; GENETIC PREDISPOSITION; GENETICS; GENOMICS; METABOLISM; NEOPLASMS; NEOPLASM; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SELENIUM; SELENOPROTEINS;

EID: 84897307986     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-38007-5_9     Document Type: Article

References (78)

1. Fairweather-Tait SJ, BaoY Broadley MR et al (2011) Selenium in human health and disease. Antiox Red Sig 14:1337–1383
2. Rayman MP (2012) Selenium and human health. Lancet 379:1256–1268
3. Whanger PD (2004) Selenium and its relationship to cancer: an update dagger. Br J Nutr 91:11–28
4. Shamberger RJ, Frost DV (1969) Possible protective effect of selenium against human cancer. Can Med Assoc J 104:82–84
5. Duffield-Lillico AJ, Reid ME, Turnbull BW et al (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 11:630–639
6. Qiao YL, Dawsey SM, Kamangar F et al (2009) Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst 101:507–518
7. Lippman SM, Klein EA, Goodman PJ et al (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 301:39–51
8. Dunn BK, Taylor PR (2012) Prostate cancer prevention and the selenium and vitamin E cancer prevention trial (SELECT): a selenium perspective. In: Hatfield D, Berry MJ, Gladyshev VN (eds) Selenium: its molecular biology and role in human health, 3rd edn. Springer, New York
9. Laclaustra M, Navas-Acien A, Stranges S et al (2009) Serum selenium concentrations and diabetes in U.S. adults: national health and nutrition examination survey (NHANES) 2003–2004. Environ Health Perspect 117:1409–1413
10. Hesketh J (2008) Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu Rev Nutr 28:157–177
11. Hesketh J, Méplan C (2011) Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: focus on selenium as an exemplar. Proc Nutr Soc epub ahead of print
12. Hesketh J, Wybranska I, Dommels Y, King M, Elliott R, Pico C, Keijer J (2006) Nutrientgene interactions in benefit-risk analysis. Br J Nutr 95(6):1232–1236
13. Méplan C (2011) Trace elements and ageing, a genomic perspective using selenium as an example. J Trace Elem Med Biol 25:S11–S16
14. Bellinger FP, Raman AV, Reeves MA et al (2009) Regulation and function of selenoproteins in human disease. Biochem J 422:11–22
15. Papp LV, Holmgren A, Khanna KK (2010) Selenium and selenoproteins in health and disease. Antioxid Redox Signal 12:793–795
16. Aachmann FL, Fomenko DE, Soragni A et al (2007) Solution structure of selenoprotein W and NMR analysis of its interaction with 14–3-3 proteins. J Biol Chem 282:37036–37044
17. Dikiy A, Novoselov SV, Fomenko DE et al (2007) SelT, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry 46:6871–6882
18. Reeves MA, Bellinger FP, Berry MJ (2010) The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid Redox Signal 12:809–818
19. Burk RF, Hill KE (2009) Selenoprotein P-expression, functions, and roles in mammals. Biochim Biophys Acta 1790:1441–1447
20. Méplan C, Nicol F, Burtle BT et al (2009) Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid Redox Signal 11:2631–2640
21. Hill KE, Zhou J, McMahan WJ et al (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 278:13640–13646
22. Schomburg L, Schweizer U, Holtmann B et al (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370:397–402
23. Al-Taie OH, Seufert J, Mork H et al (2002) A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur J Hum Genet 10:499–504
24. Bermano G, Nicol F, Dyer JA et al (1995) Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem J 311:425–430
25. Wingler K, Bocher M, Flohe L et al (1999) mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur J Biochem 259:149–157
26. Pagmantidis V, Bermano G, Villette S et al (2005) Effects of Se-depletion on glutathione peroxidase and selenoprotein W gene expression in the colon. FEBS Lett 579:792–796
27. Kipp A, Banning A, van Schothorst EM et al (2009) Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Mol Nutr Food Res 53:1561–1572
28. Bermano G, Arthur JR, Hesketh JE (1996) Role of the 30 untranslated region in the regulation of cytosolic glutathione peroxidase and phospholipid-hydroperoxide glutathione peroxidase gene expression by selenium supply. Biochem J 320:891–895
29. Méplan C, Crosley LK, Nicol F et al (2008) Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nut 87:1019–1027
30. Curran JE, Jowett JB, Elliott KS et al (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37:1234–1241
31. Voetsch B, Jin RC, Bierl C et al (2007) Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38:41–49
32. Forsberg L, de Faire U, Marklund SL et al (2000) Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol Dis 26:423–426
33. Jablonska E, Gromadzinska J, Reszka E et al (2009) Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nut 48:383–386
34. Takata Y, King IB, Lampe JW et al (2012) Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans. J Nutr 142:419–426
35. Méplan C, Crosley LK, Nicol F et al (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 21:3063–3074
36. Villette S, Kyle JA, Brown KM et al (2002) A novel single nucleotide polymorphism in the 3’ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis 29:174–178
37. Bermano G, Pagmantidis V, Holloway N et al (2007) Evidence that a polymorphism within the 30 UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr 2:225–232
38. Gautrey H, Nicol F, Sneddon AA et al (2011) A T/C polymorphism in the GPX4 30 UTR affects the selenoprotein expression pattern and cell viability in transfected Caco-2 cells. Biochim Biophys Acta 1810:584–591
39. Hu YJ, Korotkov KV, Mehta R et al (2001) Distribution and functional consequences of nucleotide polymorphisms in the 30-untranslated region of the human Sep 15 gene. Cancer Res 61:2307–2310
40. Pawlowicz Z, Zachara BA, Trafikowska U et al (1991) Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J Trace Elem Electrolytes Health Dis 5:275–277
41. Hu YJ, Diamond AM (2003) Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63:3347–3351
42. Gresner P, Gromadzinska J, Jablonska E et al (2009) Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer 65:34–40
43. Reszka E, Gromadzinska J, Jablonska E et al (2009) Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals. Clin Chem Lab Med 47:1125–1132
44. Sutherland A, Kim DH, Relton C et al (2010) Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr 5:215–223
45. Méplan C, Hughes DJ, Pardini B et al (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31:1074–1079
46. Shibata T, Arisawa T, Tahara T et al (2009) Selenoprotein S (SEPS1) gene-105G[A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol 9:2
47. Peters U, Chatterjee N, Hayes RB et al (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 17:1144–1154
48. Haug U, Poole EM, Xiao L et al (2012) Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer 51:598–605
49. Takata Y, Kristal AR, King IB et al (2011) Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the women’s health initiative observational study and meta-analysis. Cancer Epidemiol Biomarkers Prev 20:1822–1830
50. Steinbrecher A, Méplan C, Hesketh J et al (2010) Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 19:2958–2968
51. Penney KL, Schumacher FR, Li H et al (2010) A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res 3:604–610
52. Cooper ML, Adami HO, Grönberg H et al (2008) Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 68:10171–10177
53. Méplan C, Rohrmann S, Steinbrecker A et al (2012) Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status moderate risk of prostate cancer. PLOS One 7:e48709
54. Ravn-Haren G, Olsen A, Tjønneland A et al (2006) Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27:820–825
55. Cox DG, Hankinson SE, Kraft P et al (2004) No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13:1821–1822
56. Ahn J, Gammon MD, Santella RM et al (2005) No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:2459–2461
57. Knight JA, Onay UV, Wells S et al (2004) Genetic variants of GPX1 and SOD2 and breast cancer risk at the ontario site of the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 13:146–149
58. Hu J, Zhou GW, Wang N et al (2010) GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 124:425–431
59. Nasr MA, Jun Y, Hu J et al (2003) Allelic loss at the SEP15 locus in breast cancer. Cancer Ther 1:293–298
60. Ratnasinghe D, Tangrea JA, Andersen MR et al (2000) Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res 60:6381–6383
61. Yang P, Bamlet WR, Ebbert JO et al (2004) Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 25:1935–1944
62. Skuladottir H, Autrup H, Autrup J et al (2005) Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung Cancer 48:187–199
63. Lee CH, Lee KY, Choe KH et al (2006) Effects of oxidative DNA damage and genetic polymorphism of the glutathione peroxidase 1 (GPX1) and 8-oxoguanine glycosylase 1 (hOGG1) on lung cancer. J Prev Med Public Health 39:130–134
64. Raaschou-Nielsen O, Sørensen M, Hansen RD et al (2007) GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett 247:293–300
65. Rosenberger A, Illig T, Korb K et al (2008) Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC 8:60
66. Moscow JA, Schmidt L, Ingram DT et al (1994) Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis 15:2769–2773
67. Méplan C, Hesketh J (2012) The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis 27:177–186
68. Pagmantidis V, Méplan C, Van Schothorst EM et al (2008) Supplementation of healthy volunteers with nutritionally-relevant levels of selenium increases expression of lymphocyte protein biosynthesis genes. Amer J Clin Nutr 87:181–189
69. Kipp AP, Banning A, van Schothorst EM et al (2011) Marginal selenium deficiency downregulates inflammation-related genes in splenic leukocytes of the mouse. J Nutr Biochem [Epub ahead of print]
70. Gong G, Méplan C, Gautrey H et al (2012) Differential effects of selenium and knock-down of glutathione peroxidases on TNFa and flagellin inflammatory responses in gut epithelial cells. Genes Nutr 7:167–178
71. Gao Y, Feng HC, Walder K et al (2004) Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress—SelS is a novel glucose-regulated protein. FEBS Lett 563:185–190
72. Zhang K, Kaufman RJ (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454:455–462
73. Cole-Ezea P, Swan D, Shanley D et al (2012) Glutathione Peroxidase 4 has a major role in protecting mitochondria from oxidative damage and maintaining oxidative phosphorylation complexes in gut epithelial cells. Free Rad Biol Med 53:488–497
74. Seiler A, Schneider M, Forster H et al (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab 8:237–248
75. Speckmann B, Bidmon HJ, Pinto A et al (2011) Induction of glutathione peroxidase 4 expression during enterocytic cell differentiation. J Biol Chem 286:10764–10772
76. Handy DE, Lubos E, Yang Y et al (2009) Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J Biol Chem 284:11913–11921
77. Malhotra JD, Kaufman RJ (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9:2277–2293
78. Kitamura M (2011) Control of NF-jB and inflammation by the unfolded protein response. Int Rev Immunol 30:4–15